Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wilms' tumor.

D J Ganick1

  • 1Section of Pediatric Hematology/Oncology, East Carolina University School of Medicine, Greenville, North Carolina.

Hematology/Oncology Clinics of North America
|December 1, 1987
PubMed
Summary
This summary is machine-generated.

This review covers Wilms' tumor management in children, including clinical presentation, chromosomal abnormalities, and treatment effects. It discusses histopathology, prognosis, and therapeutic controversies for this childhood cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.

Cancer·1995
Same author

Skin changes associated with hematologic and oncologic diseases in children.

New York state journal of medicine·1992
Same author

Severe hematologic toxicity of valproic acid. A report of four patients.

The American journal of pediatric hematology/oncology·1990
Same author

Thoracic neuroblastoma presenting as a cystic hygroma.

Archives of disease in childhood·1988
Same author

Fine needle aspiration cytology of neuroblastoma, including peripheral neuroectodermal tumor, with immunocytochemical and ultrastructural confirmation.

Acta cytologica·1988
Same author

Clinical utility of fine needle aspiration in the diagnosis and management of neuroblastoma.

Medical and pediatric oncology·1988
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Area of Science:

  • Pediatric Oncology
  • Nephrology
  • Genetics

Background:

  • Wilms' tumor is a significant pediatric malignancy requiring comprehensive management strategies.
  • Understanding the tumor's biology and clinical course is crucial for effective treatment.
  • Current therapeutic approaches aim to optimize outcomes while minimizing long-term sequelae.

Purpose of the Study:

  • To review the clinical presentation and management of Wilms' tumor in children.
  • To discuss recent findings on chromosomal abnormalities associated with Wilms' tumor.
  • To explore the impact of histopathology on prognosis and treatment planning.

Main Methods:

  • Literature review of clinical presentations and management protocols.
  • Analysis of recent studies on genetic alterations in Wilms' tumor.

Related Experiment Videos

  • Discussion of histopathologic findings and their prognostic implications.

    • Main Results:

    • Clinical presentation varies, necessitating tailored management.
    • Chromosomal abnormalities are increasingly recognized as important in Wilms' tumor.
    • Histopathology significantly influences treatment decisions and patient outcomes.

    Conclusions:

    • Effective Wilms' tumor management integrates clinical, pathological, and genetic data.
    • Ongoing research addresses therapeutic controversies and long-term effects.
    • Optimizing treatment protocols is essential for improving survival and quality of life in pediatric patients.